Dow Up 0.08% Nasdaq Down 0.30%

Geron Corporation (GERN)

-NasdaqGS
2.25 Down 0.06(2.60%) Sep 19, 4:00PM EDT
|After Hours : 2.25 0.00 (0.00%) Sep 19, 4:40PM EDT
Prev Close:2.31
Open:2.31
Bid:2.25 x 200
Ask:2.30 x 300
1y Target Est:4.13
Beta:2.66
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:2.19 - 2.34
52wk Range:1.31 - 7.36
Volume:4,186,723
Avg Vol (3m):2,848,430
Market Cap:352.99M
P/E (ttm):N/A
EPS (ttm):-0.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNDown 2.60%352.99M
BMYUp 0.76%85.40B
GSKUp 0.19%113.81B
NVSDown 0.95%227.82B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):296.81
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.23
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-2.01

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback